Latest
The Briefing, November 1st: A New Canadian Research Center
Sanjay Singhal, a successful Canadian entrepreneur, is on a mission to transform mental health care. Creating Canada’s first psychedelic psychotherapy research center for mental health, housed out of Toronto’s University Health Network. Snajay hopes that …
The potential of 5-MeO-DMT
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
The Briefing, October 17th: Is Ketamine A Leading Market Indicator?
While most psychedelic drugs remain illegal in the United States, ketamine has been legal for use by registered practitioners since the 1960s. With the recent recognition of the compound’s use as an antidepressant, more and …
EEG study provides good news for microdosing LSD
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
The Briefing, October 4th: What Makes a Psychedelic?
Delix Therapeutics, a Boston-based startup just hit the jackpot on their initial funding round. They raised $70M to continue their research on removing the “tripping” effects from psychedelic. All with the end goal of using …
The Future of Psychedelic Clinics
The world of psychedelics is an interesting place, in which exists a potential addressable market of hundreds of billions, if not trillions, of dollars on a global basis. But for now, that potential is an …
Psychedelics for Neurodegenerative Disorders
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
Industry Unicorns and Psychedelics 2.0
It is no secret that COMPASS reached unicorn status in the psychedelic space when it recently IPO’d. With that status came a market leader moniker. And that trend continues as they set their sights on …
A Week Of “Gains” For The Industry
COMPASS Pathways has recently engaged with Hamilton Morris, a research scientist and film-maker, as a full-time consultant. Mr. Morris will be working at the COMPASS Discovery Center at the University of the Sciences in Philadelphia. …
Psychedelics For The Treatment of Addictions
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …